We are live on !
Find out more
Index Venture Associates IV Portfolio holdings
AUM
$6.24M
Turnover
0%
This Fund
S&P 500
This Quarter Est. Return
-15.33%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.24M
AUM Growth
-$1.13M
(-15%)
Cap. Flow
$0
Cap. Flow % of AUM
Cap. Flow %
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
–
Reduced
–
Closed
–
Avg Time Held
0.3
years
Top 10 Avg Time Held
0.3
years
Top 20 Avg Time Held
0.3
years
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Minerva Neurosciences
NERV
$116M
| $6.24M | 100% |
129,531
| – | – |
2019 Q4
1 quarter
|
|
Similar funds
DG
TA
PP
JA
ABC
Index Venture Associates IV's Q1 2020 Portfolio in Review
As of Q1 2020, Index Venture Associates IV held 1 position worth $6.24M, down 15% from $7.37M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q1 2020: portfolio turnover was 0%. Index Venture Associates IV opened no new positions and made no exits, leaving the 1-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- Index Venture Associates IV's ten largest holdings make up 100% of its $6.24M portfolio in Q1 2020.
- Index Venture Associates IV opened 0 new positions and closed 0 in Q1 2020.
- Index Venture Associates IV's portfolio value fell 15% quarter-over-quarter to $6.24M.
Based on Index Venture Associates IV's 13F filing for Q1 2020, filed 11 May 2020.